Fetal Alcohol Spectrum Disorder (FASD) is a neurodevelopmental disability caused by prenatal alcohol exposure (PAE). It can affect brain development, learning, memory, emotional regulation, executive functioning, and adaptive skills. Because FASD exists on a spectrum, individuals experience a wide range of cognitive, behavioural, and physical differences. Early and accurate diagnosis is essential for accessing educational supports, mental health services, financial resources, and community-based interventions that can significantly improve long-term outcomes.
However, diagnosis does not occur in a social vacuum. It happens within systems shaped by history, policy, and bias. For Black Canadians, navigating these systems often means confronting structural barriers that shape how clinicians interpret symptoms, which diagnoses they consider, and whether they make appropriate referrals. We recently published an issue paper that summarizes what we know about the intersection of Black identity and FASD and what still needs more research, policy, and practice attention.
The research gap in Canada
Despite growing awareness of racial health inequities, there is still very limited Canadian research examining the intersection of Black identity and FASD. Much of what we know about racial disparities in neurodevelopmental diagnoses comes from research conducted in the United States (U.S.) and South Africa. Although these findings cannot be directly applied to a Canadian context, they prompt important questions about how Canadian health, education, and legal systems may be responding.
The absence of race-disaggregated FASD data in Canada creates a significant blind spot. Grouping racialized communities under broad categories such as “visible minorities” obscures inequities that specifically affect Black populations. Without culturally informed and ethically governed race-based data collection, disparities remain difficult to identify, measure, or address.
Diagnostic disparities and behavioral labelling
International research demonstrates that clinicians diagnose Black youth with behavioural disorders, such as Conduct Disorder and Oppositional Defiant Disorder, more frequently. At the same time, they are less likely to receive timely diagnoses of neurodevelopmental disabilities like Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. These patterns suggest that clinicians often view Black children through a disciplinary lens rather than a neurodevelopmental one.
When clinicians do not thoroughly assess PAE, they may fail to recognize the underlying causes of cognitive and behavioural differences. This failure to properly assess prenatal alcohol exposure can lead to mislabelling, inappropriate interventions and services, and lost opportunities for early support. Misdiagnosis or delayed diagnosis of FASD limits access to specialized services and may increase the likelihood of adverse outcomes such as school exclusion, academic struggles, and involvement with child welfare or criminal legal systems.
Alcohol use myths and structural determinants of health
Some U.S.-based researchers have found that Black women reported lower average alcohol consumption during pregnancy compared to White populations, yet disparities in FASD diagnosis persisted. These persistent diagnostic disparities challenges assumptions that genetic or racial differences explain variations in prevalence. Instead, the findings point toward the role of social and structural determinants of health.
For example, factors such as limited access to prenatal care, housing instability, income inequality, geographic barriers, stigma related to substance use, and systemic discrimination all influence both risk and diagnosis. Anti-Black racism within healthcare settings can result in dismissal of concerns, inadequate screening, or biased clinical judgement. The issue is not race itself, but racism embedded in institutions and policies.
Bias in diagnostic frameworks
Clinicians often rely on facial measurements and morphological criteria to diagnose FASD that are standardized primarily on European populations. When clinicians apply these standards to Black children, they may interpret results inconsistently. For example, researchers comparing diagnostic systems have demonstrated variation in how frequently Black children are diagnosed depending on the framework used.
This potential for missed or misdiagnosis creates a troubling dual risk. Some children may be overdiagnosed because of a biased interpretation of physical features, while others may be underdiagnosed because characteristic features are missed or not recognized within diverse populations. In either situation, inequitable diagnostic practices can undermine trust in healthcare systems and contribute to disparities in access to services.
Intersectionality and compounded stigma
Black communities are not homogenous and experiences with FASD are shaped by multiple intersecting identities. For example, immigration status, adoption history, language, socioeconomic status, gender, and cultural background can influence access to healthcare and support systems. Internationally adopted children, refugees, asylum seekers, and newcomers to Canada may face additional barriers to assessment and support.
Families raising Black children with FASD may also experience compounded stigma. Negative stereotypes about alcohol use, parenting, disability, and Black communities intersect in ways that intensify discrimination. Racial trauma and cumulative experiences of racism and discrimination can affect mental health, help-seeking behaviour, and long-term wellbeing. Understanding these layered experiences requires research approaches that centre lived and living experience rather than relying solely on clinical data.
Canada needs action now
Addressing the intersection of Black identity and FASD requires more than acknowledging disparities. It demands systemic change. Ethical and culturally informed race-based data collection must be prioritized, guided by frameworks that emphasize engagement, governance, access, and protection for Black communities. Clinicians need training in anti-Black racism and implicit bias to reduce diagnostic challenges and to improve culturally responsive approaches.
Longitudinal research is also essential to understand how delayed or inaccurate diagnosis can affect life outcomes over time. Qualitative research centring Black Canadians with FASD, as well as their parents, caregivers, and families, are critical for informing policy and practice. Funding must also support culturally relevant resources for pregnant people who identify as Black and for families navigating FASD across healthcare, education, and legal systems.
The intersection of Black identity and FASD remains underexamined in Canada, yet emerging global research signals clear disparities that cannot be ignored. Bringing visibility to this issue is a necessary step towards health equity, improved diagnostic accuracy, and culturally responsive support systems.
To explore these findings in greater depth and to review the evidence behind this discussion, learn more in our latest issue paper.